Today: October 06, 2024
Today: October 06, 2024

Anti-trans bills and political climates are taking a significant mental health toll on trans and nonbinary people – even during Pride

Anti-trans bills and political climates are taking a significant mental health toll on trans and nonbinary people – even during Pride
June 12, 2023
The Los Angeles Post - The Conversation

Pride month is a time of celebration for the LGBTQ+ community, with parades and events that bring people together in joyful moments of connection. In 2023, as the LGBTQ+ community is facing unprecedented legislative attacks, I am especially reminded of the history of protest and activism that is inherently a part of Pride and its origins.

Read More

Related

Food|Health|Lifestyle

7 simple secrets to eating the Mediterranean way

7 simple secrets to eating the Mediterranean way

7 simple secrets to eating the Mediterranean way
Business|Health|Science

Pfizer's Oxbryta exit may hasten trials of rival experimental sickle cell drugs, analysts say

Pfizer's decision late on Wednesday to withdraw its sickle cell disease treatment due to the risk of death could help speed up trials of new

Pfizer's Oxbryta exit may hasten trials of rival experimental sickle cell drugs, analysts say
Business|Europe|Health|News

EU regulator recommends suspension of Pfizer's sickle cell disease treatment

The European Medicines Agency (EMA) recommended suspending the marketing authorization for Pfizer's sickle cell disease drug Oxbryta on Thursday.

EU regulator recommends suspension of Pfizer's sickle cell disease treatment
Health|News|Science

US health authorities need to play a larger role in cannabis policy, a new report says

A scientific panel is calling for a public health approach to marijuana that’s a big departure from “Just Say No.” The report was released Thursday by the National Academies of Sciences, Engineering and Medicine

US health authorities need to play a larger role in cannabis policy, a new report says
Business|Finance|Health|News|Stock Markets

Healthcare firm Guardian Pharmacy valued at about $880 million in lukewarm NYSE debut

Guardian Pharmacy's shares rose 3.3% in their NYSE debut on Thursday, giving the healthcare firm a market valuation of about $880 million, as investors remained selective about new listings

Healthcare firm Guardian Pharmacy valued at about $880 million in lukewarm NYSE debut
Share This

Popular

Health|MidEast|News|World

Israel-Hamas war latest: Israel carries out attacks in Beirut on Hezbollah targets

Israel-Hamas war latest: Israel carries out attacks in Beirut on Hezbollah targets
Health|News|Science

How to make sure your generator doesn't kill you

How to make sure your generator doesn't kill you
Education|Health|Lifestyle|News|Science

Suicide attempts increased among transgender teens when states passed anti-trans laws, study says

Suicide attempts increased among transgender teens when states passed anti-trans laws, study says
Health|News

Free Covid-19 tests are available again. Here’s how to get them

Free Covid-19 tests are available again. Here’s how to get them